❭ Research by medical division ❭ Medicine ❭ Department of Endocrinology, Morbid Obesity and Preventive Medicine ❭ Type 2 diabetes and metabolism

Type 2 diabetes and metabolism

Kåre BirkelandGroup leader
Kåre Birkeland
Group leader

Visit homepage at UiO

 

Scroll to top

Home Department of Endocrinology, Morbid Obesity and Preventive Medicine Type 2 diabetes and metabolism

  • Group members

Recent publications

Kongerud IC, Midtvedt K, Solbu MD, Øvrehus MA, Eikrem Ø, Eide IA, Heldal K, Birkeland K, Åsberg A, Jenssen TG (2026)
Can sodium-glucose cotransporter 2 (SGLT2) inhibition preserve renal structure and function in de novo kidney transplant recipients? Protocol for a randomised, double-blind, placebo-controlled trial assessing the efficacy of dapagliflozin on kidney structure, function and safety in kidney transplant recipients in Norway-the DEAK study
BMJ Open, 16 (6), e117263
DOI 10.1136/bmjopen-2026-117263, PubMed 42315275

Brito Nunes C, Rukins V, Cisse AH, White F, McBride N, Kuang A, Allard C, Ronkainen J, Hughes A, Elliott A, Thorleifsson G, Vaudel M, Laisk T, Gu Y, Lamri A, Chen L, Tuhkanen J, Lahti J, Calas L, Muntaner M, Karhunen V, Choi J, Heiskala A, Hatem G, Fragoso-Bargas N et al. (2026)
Multi-ancestry, trans-generational GWAS meta-analysis of gestational diabetes and glycaemic traits during pregnancy reveals limited evidence of pregnancy-specific genetic effects
Nat Commun, 17 (1)
DOI 10.1038/s41467-026-73509-y, PubMed 42225636

Nordheim E, Jenssen TG, Lindahl JP, Fasting KL, Hugenschmidt H, Birkeland KI, Åsberg A, Midtvedt K, Scholz H, Boye TB, Heldal K, Hagness M (2026)
[Pancreas transplantation – still a good treatment option for type 1 diabetes]
Tidsskr Nor Laegeforen, 146 (3)
DOI 10.4045/tidsskr.25.0794, PubMed 41778575

More publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)